Related Experiment Video

Updated: Aug 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Population-based incidence of severe pneumonia in children in Kiel, Germany

J A Weigl1, W Puppe, O Belke

  • 1Pediatric Infectious Diseases, Department of General Pediatrics, Christian-Albrechts-University. weigl@pediatrics.uni-kiel.de

Klinische Padiatrie
|July 21, 2005
PubMed

Insights

This study found lower community-acquired pneumonia (CAP) incidence and hospitalization rates in German children compared to the USA. Enhanced surveillance for empyema is recommended due to potential links with antibiotic resistance.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public health

Background:

  • Accurate descriptive epidemiology of community-acquired pneumonia (CAP) is essential for evaluating new vaccine impacts.
  • Understanding CAP incidence and severity in pediatric populations informs public health strategies.

Purpose of the Study:

  • To determine the population-based incidence and hospitalization rates of community-acquired pneumonia (CAP) in children aged 0-16 years in Kiel, Germany.
  • To identify causative agents and risk factors associated with CAP in this pediatric cohort.
  • To compare German CAP rates with international data, specifically the USA.

Main Methods:

  • A 4-year prospective and cross-sectional study (July 1996-June 2000) involving children admitted to pediatric hospitals in Kiel.
  • Utilized a 9-valent m-RT-PCR method for pathogen detection.
  • Included analysis of underlying chronic conditions and prematurity.

Main Results:

  • Overall incidence rate for CAP in children 0-16 years was 300 per 100,000 per year.
  • Bronchopneumonia (BPN) and pneumonia (PN) incidence rates were 163 and 136 per 100,000, respectively.
  • Respiratory Syncytial Virus (RSV) was the most common cause, particularly in infants (34%) and children under 5 (25%).
  • Hospitalization rates for severe CAP were lower than reported in the USA.
  • A significant proportion (22.8%) of children had underlying chronic conditions.

Conclusions:

  • The incidence and admission rate of severe CAP in Kiel, Germany, are lower than in the USA.
  • The high rate of empyema necessitates enhanced surveillance, potentially indicating antibiotic resistance or shifts in pneumococcal serotype prevalence.
  • Accurate epidemiological data collection, even with potential misclassification issues (e.g., ICD codes), is crucial for public health planning in Germany.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: